Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Accurate detection of the histological grade of pancreatic neuroendocrine tumors (PanNETs) is important for patients' prognoses and treatment. Traditional grading methods based on mitotic count and Ki-67 index are subjective and time-consuming. In this work, we developed and validated a pathomics model for accurate grading of PanNETs. Pathomics features were extracted from H&E whole slide images (WSIs) using Lasso regression to create a pathomics score. Its performance was evaluated in three cohorts involving 2 centers and 272 patients. This score was significantly associated with PanNET grade and could differentiate between high- and low-risk groups. In the validation and test cohorts, the pathomics model, which combined the pathomics score with clinical features, achieved AUCs of 0.85 and 0.93, respectively. In conclusion, our model enhances data processing efficiency and provides a quantitative assessment of histological features, holding promise for guiding individualized treatment and risk stratification in PanNET management.This study was registered at ClinicalTrials. Trial number: gov ChiCTR2400090898.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12246116PMC
http://dx.doi.org/10.1038/s41698-025-01032-2DOI Listing

Publication Analysis

Top Keywords

pathomics model
12
model accurate
8
accurate grading
8
pancreatic neuroendocrine
8
neuroendocrine tumors
8
pathomics score
8
pathomics
6
development validation
4
validation pathomics
4
model
4

Similar Publications

Objectives: Lymph node metastasis (LNM) is an important factor affecting the stage and prognosis of patients with lung adenocarcinoma. The purpose of this study is to explore the predictive value of the stacking ensemble learning model based on F-FDG PET/CT radiomic features and clinical risk factors for LNM in lung adenocarcinoma, and elucidate the biological basis of predictive features through pathological analysis.

Methods: Ninety patients diagnosed with lung adenocarcinoma who underwent PET/CT were retrospectively analyzed and randomly divided into the training and testing sets in a 7:3 ratio.

View Article and Find Full Text PDF

Deep Learning Based Multiomics Model for Risk Stratification of Postoperative Distant Metastasis in Colorectal Cancer.

Acad Radiol

September 2025

Department of Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang Province, China (S.D., X.N., L.Y., W.A.); Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, Zhejiang Province, China (W.A.). Electronic address:

Rationale And Objectives: To develop deep learning-based multiomics models for predicting postoperative distant metastasis (DM) and evaluating survival prognosis in colorectal cancer (CRC) patients.

Materials And Methods: This retrospective study included 521 CRC patients who underwent curative surgery at two centers. Preoperative CT and postoperative hematoxylin-eosin (HE) stained slides were collected.

View Article and Find Full Text PDF

Development and Validation of a Pathomics-Based Prognostic Model for Patients with Lung Adenocarcinoma Undergoing First-Line EGFR-TKI Therapy.

Ann Surg Oncol

September 2025

Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.

Background: Accurate prognostic prediction is crucial for personalized treatment of patients with lung adenocarcinoma (LUAD) receiving epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). This study aims to develop and validate a pathomics-based prognostic model for EGFR-TKI-treated patients with LUAD.

Patients And Methods: Data from 122 patients with LUAD who underwent first-line EGFR-TKI therapy were retrospectively analyzed.

View Article and Find Full Text PDF

Gastric cancer (GC) remains a major global health challenge, particularly in its advanced stages where prognosis is poor, and treatment responses are heterogeneous. Precision oncology aims to tailor therapies, but current biomarkers have limitations. Artificial Intelligence (AI), encompassing machine learning (ML) and deep learning (DL), offers powerful tools to analyze complex, multi-dimensional data from advanced GC patients, including clinical records, genomics, imaging (radiomics), and digital pathology (pathomics).

View Article and Find Full Text PDF

Background: Accurate subtyping and risk stratification are imperative for prognostication and clinical decision-making in small cell lung cancer (SCLC). However, traditional molecular subtyping is resource-intensive and challenging to translate into clinical practice.

Methods: A total of 517 SCLC patients and their corresponding hematoxylin and eosin (H&E)-stained whole slide images (WSIs) from three independent medical institutions were analyzed.

View Article and Find Full Text PDF